Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia

E Uyama1, T Terasaki, S Watanabe

  • 1First Department of Internal Medicine, Kumamoto University School of Medicine, Japan.

Insights

Type 3 GM1 gangliosidosis in three brothers presented as severe dystonia, impacting speech and movement from childhood. MRI revealed specific putamen lesions, suggesting their role in the disorder's symptoms.

Area of Science:

  • Neurology
  • Genetics
  • Biochemistry

Background:

  • GM1 gangliosidosis is a lysosomal storage disorder caused by deficient acid beta-galactosidase.
  • Type 3 GM1 gangliosidosis typically presents in late childhood or adulthood with progressive neurological decline.

Observation:

  • Three adult brothers (ages 28-33) with type 3 GM1 gangliosidosis exhibited generalized dystonia and dysarthria since early childhood.
  • Dystonic postures and movements persisted even during relaxation.
  • No clear correlation was found between dystonia severity and residual acid beta-galactosidase activity.

Findings:

  • Magnetic resonance imaging (MRI) demonstrated bilaterally symmetric, high-intensity lesions exclusively in the putamen on T2-weighted and proton density images.
  • These selective putaminal changes are hypothesized to be the primary cause of symptomatic dystonia in this condition.

Implications:

  • This study highlights the putamen as a critical neuroanatomical site for dystonia in type 3 GM1 gangliosidosis.
  • Understanding these specific MRI findings can aid in diagnosing and managing this rare genetic disorder.
  • Further research into the pathophysiology of putaminal degeneration in GM1 gangliosidosis is warranted.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...